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 Acute meningitis remains a devastating disease. Clinicians 
need a low threshold for suspecting meningitis, to undertake 
appropriate investigations and provide treatment in a timely 
manner, to minimise the risk of poor outcome in bacterial 
disease, while limiting unnecessary treatment in viral meningitis. 
 Deﬁnitions 
 Meningitis is inflammation of the meninges covering the 
brain. It is a pathological definition. The cerebrospinal fluid 
(CSF) typically exhibits an elevated number of leucocytes 
(or a pleocytosis). In adults, >5 leucocytes/μL is defined as 
elevated. Bacterial or viral meningitis is confirmed by the 
detection of a pathogen in the CSF. Bacterial meningitis may 
also be suggested by symptoms of meningism and appropriate 
bacteria in the blood. 1 
 Causes 
 The most common causes of meningitis in immunocompetent 
adults in the UK are viruses and bacteria. Viruses account for up to 
half of cases. Enterovirus is the commonest, with herpes simplex and 
varicella zoster the next most frequent.  Streptococcus pneumoniae 
and  Neisseria meningitidis are the commonest bacteria, together 
accounting for approximately one-quarter of cases. 
 Other causes such as  Haemophilus inﬂuenzae, Listeria 
monocytogenes, Mycobacterium tuberculosis and fungi (typically 
cryptococci) are less frequently detected, together representing 
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 Management of acute meningitis 
 Key points 
 Viral meningitis is the most common form of meningitis in the 
UK, but bacterial meningitis continues to be important, with a 
high mortality 
 Clinical features are poor discriminators for meningitis, so urgent 
investigations, starting with lumbar puncture, are key 
 Most patients do not need brain imaging before lumbar 
puncture. Patients exhibiting clinical features of brain shift 
warrant urgent CT. Otherwise, imaging can cause delays in 
commencing antibiotics, which can lead to increased mortality 
 Aim to take 10 mL of CSF during LP. Larger volumes are 
especially useful to diagnose tuberculous meningitis, and enable 
additional aliquots to be available for further diagnostic testing 
 Prompt testing of CSF and blood by PCR can hasten pathogen 
diagnosis and improve patient management
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<10% of cases. Currently, many adults with meningitis have no 
pathogen detected. 2–5 
 Although this article refers to  Listeria and tuberculous meningitis, 
it purposely focuses on the more common causes, ie viral and 
bacterial meningitis. 
 Clinical features 
 Clinical features alone cannot conﬁrm the diagnosis of meningitis. 
A lumber puncture (LP) is essential to conﬁrm the diagnosis of 
meningitis and establish the cause. 
 In one study, 95% of bacterial meningitis patients had at least 
two symptoms of headache, neck stiffness, fever and altered 
consciousness. The latter three features were present together in 
only 44% of cases. Neurological deﬁcits are found in around one-
third of patients. 6 Similar ﬁndings are reported by other studies. 7–9 
 A rash in suspected meningitis makes  N meningitidis more likely. 
However, 37% of meningococcal meningitis patients have no 
rash. 8 Varicella and enterovirus can also be associated with a rash. 
 Risk factors for  Listeria meningitis include overt or relative 
immune compromise, the latter including chronic illness, 
diabetes, alcohol dependency, malignancy or old age.  Listeria 
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meningitis is rarely seen in immunocompetent adults under 60 
years of age. 1,10 
 Travel history, symptoms of otitis media / sinusitis, contact with 
another person with meningitis, sepsis or tuberculosis are other 
useful diagnostic clues. 
 Investigations 
 Lumbar puncture 
 Lumbar puncture is the key investigation. It enables rapid 
conﬁrmation of meningitis and type of infecting organism. 
Diagnostic yield of LP can be diminished by collecting small CSF 
volumes. At least 10 mL can be safely removed. 11,12 
 Cerebrospinal ﬂ uid cell count 
 Cerebrospinal ﬂuid remains one of the most rapidly informative 
tests. Pleocytosis indicates meningeal inﬂammation, of which 
infection is the most common cause. Van de Beek and colleagues 
reported that >90% of adults with bacterial meningitis had a CSF 
leukocyte count >100 cells/μL. 6 Absence of pleocytosis makes 
meningitis much less likely, but does not completely rule it out. 
Approximately 1–2% of patients with bacterial meningitis will 
have a normal CSF leukocyte count. Positive pathogen detection 
and an absence of pleocytosis more frequently occurs among 
children, the immunocompromised, those pretreated with 
antibiotics or with mycobacteria tuberculosis infection. 13 
 Cerebrospinal ﬂ uid leukocyte differential 
 Cerebrospinal ﬂuid leukocyte differential can help predict which 
type of pathogen is causing infection. Lymphocyte predominance 
suggests viral, while neutrophil predominance suggests bacterial 
infection. There are several exceptions to this general guide, 
including CSF neutrophil predominance observed in association 
with tuberculous meningitis (Table  1 ). 
 Cerebrospinal ﬂ uid biochemistry 
 Cerebrospinal ﬂuid glucose is normally approximately two-thirds 
the blood (plasma) concentration. It is often lower in bacterial and 
tuberculous meningitis. As CSF glucose is inﬂuenced by the plasma 
glucose, it is essential to measure blood glucose at LP, to obtain an 
accurate CSF:blood glucose ratio. A CSF:blood glucose ratio <0.36 
is an accurate (93%) marker for distinguishing bacterial from viral 
meningitis. 1 
 Cerebrospinal ﬂuid protein is normally <0.4 g/L. Elevated protein 
suggests inﬂammation. A CSF protein < 0.6 g/L largely rules out 
bacterial infection. 1 
 Cerebrospinal ﬂ uid parameters 
 Cerebrospinal ﬂuid parameters have been combined into tools to 
help diagnose bacterial meningitis. One prediction rule accurately 
distinguished bacterial from viral meningitis in two adult patient 
populations using retrospective data (area under the curve 
0.97). 14,15 Clinical prediction tools (using CSF, laboratory and 
clinical parameters) have also exhibited high accuracy when tested 
retrospectively in large child populations. 16 No tools have been 
validated prospectively in adults in the UK. 
 Pathogen detection 
 Cerebrospinal ﬂ uid microscopy with Gram stain 
 Cerebrospinal ﬂuid microscopy with Gram stain (or an acid fast 
stain for  M tuberculosis ) can rapidly detect bacteria. It has a 
sensitivity between 50% and 99%. 6 Detection, particularly for 
 M tuberculosis , is enhanced by collection of >10 mL of CSF and 
subsequent cytospin. 11 
 Cerebrospinal ﬂ uid culture 
 Cerebrospinal ﬂuid culture is historically regarded as the 
‘gold standard’ for the diagnosis of bacterial meningitis. It is 
diagnostic in 70–85% of cases prior to antibiotic exposure. 
Sensitivity decreases by 20% following antibiotic pretreatment. 
Cerebrospinal ﬂuid sterilization can occur within 2–4 hours of 
antibiotic administration for meningococci and pneumococci 
respectively. 15 Lumbar puncture should be performed as soon as 
possible to maximise pathogen detection. 
 Table 1.  Classical cerebrospinal fluid features for different causes of meningitis a 
  Normal  Bacterial  Viral  Tuberculous  Fungal 
Opening presssure (cm CSF) 12–20 Raised Normal / mildly raised Raised Raised
Appearance Clear Purulent, turbid, cloudy Clear Clear or cloudy Clear or cloudy
CSF WBC (cells/μL) <5 Raised (>100) b Raised (5–1000) b Raised (5–100) b Raised (5–100) b 
Predominant cell n/a Neutrophils c Lymphocytes d Lymphocytes e Lymphocytes
CSF protein (g/L)  Raised Mildly raised Markedly raised Raised
CSF plasma glucose ratio >0.66 Very low Normal / slightly low Very low Low
CSF glucose (mmol) 2.6–4.5 Very low Normal / slightly low Very low Low
 Note: Local laboratory ranges for biochemical tests should be consulted. They may vary from the quoted values here. A traumatic lumbar puncture (LP) will affect the 
results by falsely elevating the white cells due to excessive red cells. A common correction factor used is 1:1000. 
 aDerived from Tom Solomon–Lecture Notes in Neurology 
 bOccasionally the CSF white cell count (WCC) may be very high (several thousand) in bacterial meningitis. Alternatively the CSF WCC may be normal (especially in 
immunodeficiency or tuberculous meningitis). 
 cMay be lymphocytic if antibiotics given before LP (partially treated bacterial meningitis),  or with certain bacteria, eg  Listeria monocytogenes. 
 dMay be neutrophilic in enteroviral meningitis (especially early in disease). 
 eMay be neutrophilic early in the disease course. 
 CSF = cerebrospinal fluid; WBC = white blood cell count; WCC = white cell count 
CMJv18n2-CMEGriffiths.indd   165 3/24/18   6:11 PM
166 © Royal College of Physicians 2018. All rights reserved.
CME Infectious diseases
 Cerebrospinal ﬂ uid polymerase chain reaction 
 Cerebrospinal ﬂuid polymerase chain reaction (PCR), using 
pathogen speciﬁc nucleic acid sequences, can detect both bacteria 
and viruses with high sensitivity. Polymerase chain reaction is 
the ‘gold standard’ for diagnosis of viral meningitis. Polymerase 
chain reaction is increasingly relied upon in bacterial meningitis. It 
has far greater sensitivity than culture in invasive meningococcal 
disease.17 Cerebrospinal ﬂuid PCR is particularly valuable in 
patients who receive antibiotics before LP. Polymerase chain 
reaction for 16S ribosomal RNA (present in almost all bacteria) 
enables a broad screen for bacteria, but has lower sensitivity than 
pathogen speciﬁc PCR. 1,15 
 Blood tests 
 Blood cultures should always be taken on admission and are 
helpful when antibiotics are started before LP. Blood cultures are 
positive in 50–80% of bacterial meningitis cases. 15 
 Blood PCR is increasingly important, especially as PCR detects 
bacteria several days after antibiotic initiation. 17 Blood PCR 
substantially increases the conﬁrmation in meningococcal disease. 18 
 Despite these tests, many patients will not have a cause 
identiﬁed for their meningitis. 
 Blood biomarkers, such as procalcitonin and C-reactive protein, 
can help distinguish bacterial from viral meningitis in adults and can 
be used to help guide treatment if no aetiology is found. 19,20 Host 
biomarkers for detecting bacterial meningitis are being actively 
investigated by our Liverpool group and others. To date, there is 
insufﬁcient evidence to recommend their routine use in the NHS. 1 
 Swabs 
 Throat, nasopharyngeal, and stool swabs are useful for detecting 
enteroviruses if the CSF PCR is negative. 
 Brain imaging 
 Brain imaging is neither obligatory in the management of 
meningitis, nor a prerequisite to LP. Performing neuroimaging 
before LP is associated with delays in commencing antibiotics, 
which in turn can lead to an increase in mortality. 12,21 An urgent 
CT scan should be performed if there are clinical signs of brain 
shift. Clinical features indicative of a brain shift include focal 
neurological signs and reduced Glasgow Coma Score (GCS) 
(Box 1). The 2016 UK meningitis guidelines recommend an LP 
be performed without prior neuroimaging if the GCS is >12. 1 
Patients with a GCS ≤12 should be considered for critical care, 
 Box 1.  Indications for brain imaging before lumbar 
puncture (LP) in suspected meningitis a 
> Focal neurological signs
> Presence of papilloedema b 
> Continuous or uncontrolled seizures GCS12 c 
 a To exclude significant brain swelling or shift that may predispose to cerebral 
herniation post LP.
 b Inability to view the fundus is not a contraindication to LP, especially in 
patients who have had a short duration of symptoms.
 c Lumbar puncture without prior neuroimaging may be safe at levels below this.
GCS = Glasgow Coma Score
intubation assessment and neuroimaging. Imaging, particularly 
when contrast is used, may exhibit meningeal enhancement in 
meningitis. When brain shift is identiﬁed liaison with critical care 
and neurosurgical teams are essential. 
 A summary of investigations is presented in Fig 1. 
 Treatment 
 If a patient exhibits signs of airway, breathing or circulatory 
difﬁculties (eg in coexisting sepsis), management should initially 
focus on stabilisation of these systems. 
 All patients should be reviewed by a senior clinician. The Royal 
College of Physicians recommends consultant review for all 
acute medical patients within 14 hours of admission. Urgency 
of review should be assessed using the National Early Warning 
Score. The GCS should be recorded for its prognostic value, and 
to enable changes to be monitored. Presence of a rash and use of 
preadmission antibiotics should also be recorded. 
 If the patient presents with sepsis, they should be managed 
according to the sepsis guidelines. 22 If the infective focus 
of sepsis is meningitis, then the antibiotic treatment should 
follow the guidelines for meningitis. 1 For example, piperacillin/
tazobactam is not recommended for use in sepsis secondary to 
meningitis, because of its poor penetration of the blood brain 
barrier. A recent large open-label trial showed no beneﬁt of 
prehospital antibiotics in sepsis. 23 Previous trials for meningitis 
have also been inconclusive. 1 Consequently, the beneﬁt of 
prehospital antibiotics for suspected meningitis is unclear. 
Management of other aspects of sepsis, eg circulation, should 
follow the sepsis guidelines. 22 
 Treatment for bacterial meningitis is antibiotics, with or without 
steroids. The choice of antibiotics is a three stage process: an initial 
empirical decision based on clinical suspicion, review following 
microscopy results, and review again when culture or PCR results 
are available (Fig 2). 
 In suspected bacterial meningitis, dexamethasone should be 
started either shortly before or simultaneously with antibiotics 
at 10 mg intravenously (IV) 6-hourly. Up until 12 hours after 
antibiotic initiation, dexamethasone can still be started, 
but the impact of this on mortality has not been studied. If 
pneumococcal meningitis is probable, dexamethasone should 
continue for 4 days. In suspected tuberculous meningitis, 
dexamethasone provision should follow the recommended 
guidelines. 11 Once another cause of meningitis is probable, 
dexamethasone should be stopped. 
 There is no speciﬁc treatment for viral meningitis. Treatment with 
aciclovir has only been of proven beneﬁt in herpes encephalitis, 
not meningitis. Only if the patient has encephalitic features, 
such as impairment of consciousness, focal neurological signs, 
inﬂammation of brain parenchyma in the region of the temporal 
lobe on cranial imaging, should aciclovir be considered. 
 Prognosis 
 Mortality occurs almost exclusively in bacterial meningitis. Up to 
57% in meningococcal sepsis, 30% of pneumococcal and 7% of 
meningococcal meningitis without sepsis cases die. 1,6 
 Morbidity is common in bacterial meningitis. Van De Beek’s 
study reported focal neurological deﬁcits in 50% of cases, the 
commonest being hearing impairment (14%), and 14% of cases 
exhibited moderate to severe disability at discharge. 6 
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Paent with suspected meningis
Bloods Blood cultures
Full blood count, urea, creanine,
electrolytes, liver funcon tests and
clong screen
Procalcitonin or CRP 
Meningococcal and pneumococcal PCR
Serology sample
Glucose (pair with CSF glucose)
HIV Ab/Ag test
CSF No signs of sepsis or shocka
Opening pressure
Microscopy, culture and sensivity
Glucose (pair with plasma glucose)
Protein
If bacterial meningis seems likely
based on CSF (WBC, Diﬀ, Prot, Glu Rao)
PCR for meningococcal and pneumococcal 
If viral meningis seems likely:
PCR for enterovirus, HSV 1, HSV 2, and VZV
aIf any of the following features are
present LP should be delayed:
> Signs of severe sepsis or rapidly
   evolving rash
> Respiratory or cardiac compromise
> Ancoagulant therapy / known
   thrombocytopenia
> Infecon at the site of LP
> Focal neurological signsb 
> Presence of papilloedemab,c
> Connuous or uncontrolled seizures†
> GCS ≤12b,d
cinability to see the fundus is not a
contraindicaon to LP
dLP may be safe at lower levels of
consciousness
bNeuroimaging should be performed
before LP for these indicaons
Once the paent is stable and if
meningis is likely (with or without
sepsis) an LP may sll be diagnoscally
useful, even aer several days.
Further
tests
(If no aeologyidenﬁed on above tests) 
M
oving from
 ﬁrst-line to secondary invesgaons
If bacterial meningis sll seems likely:
16S rRNAPCR on CSF or blood
If viral meningis sll seems likely:
Stool for enterovirus PCR
Throat swab for enterovirus PCR
CSF PCR for viruses directed by history
eg Parechovirus
Consider other pathogens
PCR for MTb
Cryptococcalangen test 
 Fig 1.  Investigations algorithm. CSF = cerebrospinal ﬂ uid; CRP = C-reactive protein; Diff = white cell differential; GCS = Glasgow Coma Scale; Glu = glucose 
(CSF:blood ratio); HSV = herpes simplex virus; LP = lumbar puncture; Mtb = Mycobacterium tuberculosis; PCR = polymerase chain reaction; Prot = CSF 
Protein; VZV = varicella zoster virus; rRNA = ribosomal ribonucleic acid  
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Step 1. Suspect pyogenic bacterial meningis
(assuming Streptococcus pneumonia or Neisseria meningides) 
a. Start ceriaxone 2 g IV 12-hourlya (or cefotaxime 2 g IV 6-hourly) 
b. In paents with probable meningococcal sepsis not treated with ceriaxone, give a single
    dose of ciproﬂoxacin 500 mg orally (to eliminate carriage) 
c. In paents at risk for Listeria monocytogenes, such as paents with relave immunocompromise
    or old ageb), consider adding in amplicillin/amoxycillin (step 2iiib).
aIf the paent has a history of
anaphylaxis to cephalosporins or
penicillin:  
Step 1a. Start Chloramphenicol
25 mg/kg IV 6-hourly 
Step 1c. Add in co-trimoxazole
10–20 mg/kg (of the trimethoprim
component) in four divided doses.1
bSurveillance studies indicate
invasive Listeria or Listeria
meningis is rare in
immunocompetent adults aged
under 60 years. Nevertheless, early
meningis guidelines recommend
covering for Listeria in adults
above 50 years of age.1,10,25 
Up-to-date informaon on countries
exhibing anbioc resistance can
be obtained via the European
Centre for Disease Prevenon and
Control website or the
World Health Organizaon
(hp://bit.ly/1Kosckx and
hp://bit.ly/1rOb3cx)
Step 2. Review aer Gram stain
i. Gram-posive diplococci – likely Streptococcus pneumoniae 
  a. Connue as step 1a (empiric treatment)
  b. If the paent visited a country with suspected penicillin resistancea
   Add vancomycin 15–20 mg/kg IV 12-hourly unl resistance data available
   Alternavely, add rifampicin 600 mg IV (or orally )12-hourly 
   Rifampicin should be used instead of vancomycin in renal failure
ii. Gram-negave diplococci – likely Neisseria meningidis 
  a. Connue as step 1a
iii. Gram-posive bacilli – suggesve of Listeria monocytogenes 
  a. Connue as step 1a
  b. Add ampicillin/amoxicillin 2 g IV 4-hourly
iv. Gram-negave rods – suggesve of Enterobacteriaceae 
  a. Connue as step 1a
  b. Seek specialist advice on local anmicrobial resistance 
  c. If high suspicion of extended spectrum beta lactamase (ESBL) resistance switch to
   meropenem 2 g IV 8-hourly
Step 3. Review when culture/PCR results available 
i. Streptococcus pneumoniae conﬁrmed 
  a. If penicillin sensive (MIC ≤0.06 mg/L) 
   Connue as step 1a (or switch to benzylpenicillin 2.4 g IV 4-hourly ) 
  b. If penicillin resistant (MIC >0.06) but cephalosporin sensive 
   Connue as step 1a 
  c. If penicillin and cephalosporin resistant 
   Add vancomycin 15–20 mg/kg IV 12-hourly and rifampicin 600 mg IV/orally 12-hourly 
  d. If anbioc sensivity for organism not known (eg. pathogen PCR data only)
   Connue as step 2i (as for Gram-posive diplococci) 
  e. In paents recovered by day 10, treatment should stop. Otherwise treat for 14 days
  f. In all cases of penicillin or cephalosporin resistance, treat for 14 days
ii. Neisseria meningidis 
  a. Connue as step 1a (or switch to benzylpenicillin 2.4 g IV 4-hourly ) 
  b. For paents recovered by day 5, treatment can stop 
iii. Listeria monocytogenes 
  a. Switch to ampicillin/amoxicillin 2 g IV 4-hourly 
  b. Alternavely, give co-trimoxazole 10–20 mg/kg in four divided doses
   (of trimethoprim component) in paents with a history of anaphylaxis to beta lactams 
  c. Treat for at least 21 days 
iv. Haemophilus inﬂuenzae 
  a. Connue step 1a 
  b. Treat for 10 days 
v. Enterobacteriaceae 
  a. Connue as step 2 iv (for Gram-negave rods ) 
  b. Treat for 21 days
 Fig 2.  Three steps for antibiotic treatment in suspected pyogenic bacterial meningitis. IV = intravenous; MIC = minimal inhibitory concentration 
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 Few studies have examined outcome in viral meningitis. One 
recent study, reported one-third of adult varicella meningitis 
patients (3/9) suffered sequelae. 24 In our experience, viral 
meningitis patients can suffer cognitive and psychological 
sequelae. Headaches occur in one-third of patients. Where there 
is concern, patients should access neuropsychological services, 
which can help detect subtle impairments and may facilitate 
functional recovery. Organisations such as the Meningitis Research 
Foundation ( www.meningitis.org ) or Meningitis Now ( www.
meningitisnow.org ), can also provide helpful patient information 
and advocacy. 
 Conclusion 
 Many meningitis patients in the UK who have a CSF pleocytosis 
never have a pathogen identiﬁed. Clinicians need to remain 
vigilant and treat suspected bacterial meningitis promptly. 
However, with viruses being the most common cause of 
meningitis, rapid diagnosis via PCR can limit unnecessary antibiotic 
treatment and expedite hospital discharge. ■ 
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